Xth Eurasian Hematology-Oncology Congress

http://www.ehog.net/

 

Bone Marrow Allogenic Transplantation in Relapsed/ Refractory Hem Malignancies: IO Is Effective Bridging Strategy, and to Treat Relapses After HSCT, alloHSCT Technology Is Improving

11 views
December 13, 2019
Comments 0
Login to view comments. Click here to Login